Abstract: Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder of which prevalence has been increasing steadily all over the world. There is a need of understanding the role of tobacco products in diabetes mellitus, especially smokeless tobacco (ST) products. Objective: To analyze if ST is a determinant for T2DM among patients in South East Asia Region (SEAR) and secondly to obtain the pooled prevalence of use of ST in T2DM patients/participants from these studies. Materials and Methods: PubMed, Google Scholar, EBSCO, and Scopus are the databases that were searched to find desired manuscripts, which fulfilled the inclusion criteria to undertake this systematic review and meta-analysis (SRMA). Meta-analysis was carried out to determine the pooled effect size for the odds ratio of ST use in T2DM with 95% CI. MedCalc statistical software was used followed by the DerSimonian and Laird method under the random effect model. Results: A total of 8 manuscripts were involved in the systematic review and 7 in the meta-analysis. Odds of 1.39 indicating increased frequency of using ST among T2DM patients or survey participants was observed, which was not significant with C.I. 95% (0.843–2.288) and P < 0.001 with high heterogeneity. The pooled prevalence of use of ST in T2DM is 24.08% (CI 15.67 to 33.64) under random effect model with I2 inconsistency of 97.16% in 8 studies from India and Bangladesh. Conclusion: This pooled analysis shows that ST use is not a risk factor for T2DM. The number of studies included in the SRMA from SEAR is limited having no representation from Myanmar, Bhutan, Timor Leste, and Sri Lanka.
Processing Request
No Comments.